 |
|
|
|
| Selected Reading |
 Abdullah ASM, Tomlinson B, Cockram CS, et al. Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 2003 Sep;9(9):1042-5 [Full text]
Aghaizu A, Elam G, Ncube F, et al. Preventing the next 'SARS'--European healthcare workers' attitudes towards monitoring their health for the surveillance of newly emerging infections: qualitative study. BMC Pub Health 2011 Jul 8;11:541 [Abstract]
Ahuja AT, Wong JKT. Radiological appearances of recent cases of atypical pneumonia in Hong Kong. On Web site of Chinese University of Hong Kong, Dept of Diagnostic Radiology & Organ Imaging
[Full text]
Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drug. Science 2003 Jun 13;300(5626):1763-7 [Abstract]
Antia R, Regoes RR, Koella JC, et al. The role of evolution in the emergence of infectious diseases. (Letter) Nature 2003 Dec 10;426(6967):658-61 [Abstract]
Arguin PM, Navin AW, Steele SF, et al. Health communication during SARS. Emerg Infect Dis 2004 Feb;10(2):377-80 [Full text]
Bassetti S, Bischoff WE, Sherertz RJ. Are SARS superspreaders cloud adults? (Letter) Emerg Infect Dis 2005 Apr;11(4):637-8 [Full text]
Bell DM, for World Health Organization Working Group on Prevention of International and Community Transmission of SARS. Public health interventions and SARS spread, 2003. Emerg Infect Dis 2004 Nov;10(11):1900-6 [Full text]
Bergeron SL, Sanchez AL. Media effects on students during SARS outbreak. Emerg Infect Dis 2005 May;11(5):732-4 [Full text]
Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci 2004 Apr 27;101(17):6641-6 [Abstract]
Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003 Oct;112:e261 [Abstract]
Bitnun A, Read S, Tellier R, et al. Severe acute respiratory syndrome-associated coronavirus infection in Toronto children: a second look. Pediatrics 2009 Jan;123(1):97-101 [Abstract]
Blendon RJ, Benson JM, DesRoches CM, et al. The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis 2004 Apr 1;38(7):925-31 [Abstract]
Bloom BR. Lessons from SARS. (Editorial) Science 2003 May 2;300(5620):701 [Full text]
Booth TF, Kournikakis B, Bastien N, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005 May 1;191(9):1472-7 [Abstract - See also Tong below]
Breiman RF, Evans MR, Preiser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003 Sep;9(9):1037-41 [Full text]
Breugelmans JG, Zucs P, Porten K, et al. SARS transmission and commerical aircraft. (Letter) Emerg Infect Dis 2004 Aug;10(8):1502-3 [Full text]
Brown EG, Tetro JA. Comparative analysis of the SARS coronavirus genome: a good start to a long journey. (Commentary) Lancet 2003 May 24;361(9371):1756-7 [Abstract]
Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci 2004 Jun 29;101(26):9804-9 [Full text]
Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004 Jun 26;363(9427):2122-7 [Abstract]
Bull K, Dykhuizen D. Virus evolution: epidemics-in-waiting. (Editorial) Nature 2003 Dec 10;426(6967):609-10 [Full text]
Cameron MJ, Ran L, Xu L, et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 2007 Aug;81(16):8692-707 [Abstract]
Cameron PA. The plague within: an Australian doctor's experience of SARS in Hong Kong. (Personal Perspective) Med J Aust 2003 May 19;178(10):512-3 [Abstract]
Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med 2006 Dec 14;4:32 [Abstract]
Cao WC, Zhang PH, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. (Letter) N Engl J Med 2007 Sep 13;357(11):1162-3 [Full text]
Cauchemez S, Boelle PY, Donnelly CA, et al. Real-time estimates in early detection of SARS. Emerg Infect Dis 2005 Jan;12(1):110-3 [Full text]
CDC. Clinical guidance on the identification and evaluation of possible SARS-CoV disease among persons presenting with community-acquired illness. Originally published Dec 3, 2003. Updated May 3, 2005 [Full text]
CDC. Efficiency of quarantine during an epidemic of severe acute respiratory syndrome: Beijing, China, 2003. MMWR 2003 Oct 31;52(43):1037-40 [Full text]
CDC. Fact sheet for SARS patients and their close contacts. May 3, 2005 [Web page]
CDC. Fact Sheet: Basic information about SARS. May 3, 2005 [Full text]
CDC. Guidance about SARS for airline flight crews, cargo and cleaning personnel, and personnel interacting with arriving passengers. May 3, 2005 [Full text]
CDC. Guidance about SARS for Americans living abroad. May 3, 2005 [Web page]
CDC. Guidance about SARS for persons traveling to areas where SARS cases have been reported. May 3, 2005 [Web page]
CDC. Guidance for SARS preparedness for infection control. Sep 29, 2003 [Full text]
CDC. Guidance for surveillance and early detection of SARS. Sep 11, 2003 [Full text]
CDC. Guidance on air medical transport for SARS patients. May 3, 2005 [Full text]
CDC. Guidelines for collection of specimens from potential cases of SARS. May 3, 2005 [Full text]
CDC. Guidelines for laboratory diagnosis of SARS-CoV infection. May 3, 2005 [Full text]
CDC. In the absence of SARS-CoV transmission worldwide: guidance for surveillance, clinical and laboratory evaluation, and reporting. Published Dec 3, 2003; updated May 3, 2005 [Full text]
CDC. Inclusion of official counts of SARS-CoV disease in National Notifiable Diseases Surveillance System data presentation. MMWR 2003 Dec 12;52(49):1210 [Full text]
CDC. Preliminary clinical description of severe acute respiratory syndrome. MMWR 2003 Mar 28;52(12):255-6 [Full text]
CDC. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. MMWR 2003 Oct 17;52(41):986-7 [Full text]
CDC. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Jan 8, 2004 [Full text]
CDC. Revised US surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases: United States and worldwide, December 2003. MMWR 2003 Dec 12;52(49):1202-6 [Full text]
CDC. SARS, influenza, and use of influenza vaccine. MMWR 2003 Oct 3;52(39):941-2 [Full text]
CDC. Severe acute respiratory syndrome: worldwide and United States, 2003. MMWR Jul 18;52(28):664-5 [Full text]
CDC. Updated interim U.S. case definition of SARS. May 3, 2005 [Full text]
CDC. Use of quarantine to prevent transmission of SARS: Taiwan, 2003. MMWR 2003 Jul 25;52(29):680-3 [Full text]
Chan KH, Poon LL, Cheng VCC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004 Feb;10(2):294-9 [Full text]
Chan KH, Sonnenberg K, Niedrig M, et al. Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol 2007 Nov;14(11):1433-6 [Abstract]
Chan LH, Chen L, Xu J. China's engagement with global health diplomacy: was SARS a watershed? PLoS Med 2010 Apr 27;7(4):e1000266 [Full text]
Chan LY, Lee N, Chan PKS, et al. Diagnostic criteria during SARS outbreak in Hong Kong. (Letter) Emerg Infect Dis 2004 Jun;10(6):1168-70 [Full text]
Chan PK, Lim PL, Liu EY, et al. Antibody avidity maturation during severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2005 Jul 1;192(1):166-9 [Abstract]
Chan PKS, Ip M, Ng KC, et al. Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003 Nov;9(11):1453-4 [Full text]
Chan PKS, Tam JS, Lam C-W, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003 Sep;9(9):1058-63 [Full text]
Chan PKS, To W-K, Ng K-C, et al. Laboratory diagnosis of SARS. Emerg Infect Dis 2004 May;10(5):825-31 [Full text]
Chang W-T, Kao C-L, Chung M-Y, et al. SARS exposure and emergency department workers. Emerg Infect Dis 2004 Jun;10(6):1117-9 [Full text]
Che XY, Hao W, Wang Y, et al. Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis 2004 Nov;10(11):1947-9 [Full text]
Chen C, Zhao B, Yang X, et al. Role of two-way airflow owing to temperature difference in severe acute respiratory syndrome transmission: revisiting the largest nosocomial severe acute respiratory syndrome outbreak in Hong Kong. J R Soc Interface 2011 May 6;8(58):699-710 [Abstract]
Chen L, Gui C, Luo X, et al. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005 June 1;79(11):7095-103 [Abstract]
Chen L, Liu P, Gao H, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004 Nov 15;39(10):1531-5 [Abstract]
Chen NH, Wang PC, Hsieh MJ, et al. Impact of severe acute respiratory syndrome care on the general health status of healthcare workers in Taiwan. Infect Control Hosp Epidemiol 2007 Jan;28(1):75-9 [Abstract]
Chen W, Yan M, Yang L, et al. SARS-associated coronavirus transmitted from human to pig. Emerg Infect Dis 2005 Mar;11(3):446-8 [Full text]
Chen WJ, Yang JY, Lin JH, et al. Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin Infect Dis 2006 Jun 1;42(11):1561-9 [Abstract]
Chen WK, Wu HD, Lin CC, et al. Emergency department response to SARS, Taiwan. Emerg Infect Dis 2005 Jul;11(7):1067-73 [Full text]
Chen WQ, Ling WH, Lu CY, et al. Which preventive measures might protect health care workers from SARS? BMC Public Health 2009 Mar 13;9:81 [Abstract]
Chen WQ, Lu CY, Wong TW, et al. Anti-SARS-CoV immunoglobulin G in healthcare workers. Emerg Infect Dis 2005 Jan;11(1):89-94 [Full text]
Chen X, Zhou B, Li Meizhong L, et al. Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J Infect Dis 2004 Apr 1;189(7):1158-63 [Abstract]
Chen XP, Cao Y. Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome. Clin Infect Dis 2004 Apr 1;38(7):1030-2 [Abstract]
Chen Y-C, Chen P-J, Chang S-C, et al. Infection control and SARS transmission among healthcare workers, Taiwan. Emerg Infect Dis 2004 May;10(5):895-8 [Full text]
Chen Y-C, Huang L-M, Chan C-C, et al. SARS in hospital emergency room. Emerg Infect Dis 2004 May;10(5):782-8 [Full text]
Chen YM, Liang SY, Shih Yp, et al. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol 2006 Feb;44(2):359-65 [Abstract]
Cheng VCC, Hung IFN, Tang BSF, et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 2004 Feb 15;38(4):467-75 [Abstract]
Cheng VCC, Lau SKP, Woo PCY, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007 Oct;20(4):660-94 [Abstract]
Cheung CY, Poon LL, Ng IH, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macorphages in vitro: possible relevance to pathogenesis. J Virol 2005 Jun;79(12):7819-26 [Abstract]
Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004 Mar 12;303(5664):1666-9 [Abstract]
Chiu SS, Chan KH, Chu KW, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 2005 Jun 15;40(12):1721-9 [Abstract]
Choi SMY, Lam PY. Enhancing legal preparedness for the prevention and control of infectious diseases: experience from severe acute respiratory syndrome in Hong Kong. Public Health 2009 Mar;123(3):242-6 [Abstract]
Chow PKJ, Ooi E-E, Tan H-K, et al. Healthcare worker seroconversion in SARS outbreak. Emerg Infect Dis 2004 Feb;10(2):249-50 [Full text]
Chowell G, Castillo-Chavez C, Fenimore PW, et al. Model parameters and outbreak control for SARS. Emerg Infect Dis 2004 Jul;10(7):1258-63 [Full text]
Christian MD, Loutfy M, McDonal LC, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004 Feb;10(2):287-93 [Full text]
Christian MD, Poutanen SM, Loutify MR, et al. Severe acute respiratory syndrome. Clin Infect Dis 2004 May 15;38(10):1420-7 [Abstract]
Chu CM, Cheng VC, Hung IF, et al. Viral load distribution in SARS outbreak. Emerg Infect Dis 2005 Dec;11(12):1882-6 [Full text]
Colizza V, Barrat A, Barthelemy M, et al. Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study. BMC Med 2007 Nov 21;5:34 [Abstract]
Cowling BJ, Muller MP, Wong IO, et al. Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings. Arch Intern Med 2006 Jul 24;155(14):1505-11 [Abstract]
Danesh A, Cameron CM, Leon AJ, et al. Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. Virology 2011 Jan 5;409(1):102-12 [Abstract]
Darnell MER, Plant EP, Watanabe H, et al. Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets. J Infect Dis 2007 Nov 1;196(9):1329-38 [Abstract]
de Lang A, Baas T, Teal T, et al. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog 2007 Aug;3(8):e112 [Full text]
Derrick JL, Gomersall CD. Surgical helmets and SARS infection. Emerg Infect Dis 2004 Feb;10(2):277-9 [Full text]
Des Jarlais DC, Stuber J, Tracy M, et al. Social factors associated with AIDS and SARS. Emerg Infect Dis 2005 Nov;11(11):1767-9 [Full text]
Desenclos J-C, Van der Werf S, Bonmarin I, et al. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis 2004 Feb;10(2):195-200 [Full text]
Dimoulas P, Green KA, Shigayeva A, et al. Patient contact recall after SARS exposure. Emerg Infect Dis 2005 Apr;11(4):625-8 [Full text]
Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004 Jun;203(2):622-30 [Abstract]
Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003 May 24;361(9371):1761-6 [Abstract]
Dowell SF, Simmerman JM, Erdman DD, et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis 2004 Sep 1;39(5):652-7 [Abstract]
Drazen JM. Case clusters of the severe acute respiratory syndrome. (Editorial) N Engl J Med 2003 May 15;348(20):e6-7 [Full text]
Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 May 15;348(20):1967-76 [Full text]
Du L, He Y, Zhou Y, et al. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol 2009 Mar;7(3):226-36 [Abstract]
Emery SL, Erdman DD, Bowen MD, et al. Real-time reverse transciption-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004 Feb;10(2):311-6 [Full text]
Enserink M. SARS: a pandemic prevented. (Breakthrough of the year) Science 2003 Dec 19;302(5653):2045 [Abstract]
Esswein EJ, Kiefer M, Wallingford K, et al. Environmental and occupational health response to SARS, Taiwan, 2003. Emerg Infect Dis 2004 Jul;10(7):1187-94 [Full text]
Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. (Commentary) Lancet 2003 Apr 19;361(9366):1312-3 [Full text]
Farcas GA, Poutanen SM, Mazzulli T, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2005 Jan 15;191(2):193-7 [Abstract]
FDA. FDA issues guidance on severe acute respiratory syndrome to further safeguard the blood supply. FDA Talk Paper. Apr 17, 2003 [Full text]
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]
Fouchier RA, Hartwig NG, Bestegroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci 2004 Apr 20;101(16):6212-6 [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Frieman M, Yount B, Agnihothram S, et al. Molecular determinants of SARS coronavirus pathogenesis and virulence in young and aged mouse models of human disease. J Virol 2011 (published online Nov 9) [Abstract]
Fung CP, Hsieh TL, Tan KH, et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 2004 Dec;25(12):1026-32 [Abstract]
Galvani AP, Lei X, Jewell NP. Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis 2003 Aug;9(8):991-4 [Full text]
Gamage B, Moore D, Copes R, et al. Protecting health care workers from SARS and other respiratory pathogens: A review of the infection control literature. Am J Infect Control 2005 Mar;22(2):114-21 [Abstract]
GAO (General Accounting Office). SARS: established infectious disease control measures helped contain spread, but a large-scale resurgence may pose challenges. Statement of Marjorie Kanof before Senate Permanent Subcommittee on Investigation, Committee on Governmental Affairs. GAO-03-105 [Full text]
Gao W, Tamin A, Soloff A, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003 Dec 6;362(9399):1895-6 [Abstract]
Gerberding JL. Faster . . . but fast enough? Responding to the epidemic of severe acute respiratory syndrome. (Editorial) N Engl J Med 2003 May 15;348(20):2030-1 [Full text]
Goh DL-M, Lee BW, Chia KS, et al. Secondary household transmission of SARS, Singapore. Emerg Infect Dis 2004 Feb;10(2):232-4 [Full text]
Goldsmith CS, Tatti KM, Ksiazek TG, et al. Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 2004 Feb;10(2):320-6 [Full text]
Gopolakrishna G, Choo P, Leo YS, et al. SARS transmission and hospital containment. Emerg Infect Dis 2004 Mar;10(3):395-400 [Full text]
Gorbalenya AE, Snijder EJ, Spaan WJM. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol 2004 Aug;78(15):7863-6 [Full text]
Groneberg DA, Poutanen SM, Low DE, et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005 Mar;5(3):147-55 [Abstract]
Guan Y, Zheng YQ, He XL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 2003 Oct 10;302(5643):276-8 [Abstract]
Ha LD, Bloom SA, Hien NQ, et al. Lack of SARS transmission among public hospital workers, Vietnam. Emerg Infect Dis 2004 Feb;10(2):265-8 [Full text]
Haagmans BL, Kuiken T, Martina BE, et al. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004 Mar;10(3):290-3 [Abstract]
Haagmans BL, Osterhaus AD. Nonhuman primate models for SARS. (Perspective) PLoS Med 2006 May;3(5):e194 [Full text]
Hamburg MA. SARS threat preparedness. Testimony before Government Reform Committee, US House of Representatives, 108th Congress. Apr 9, 2003 [Full text]
Hawryluck L, Gold WL, Robinson S, et al. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis 2004 Jul;10(7):1206-12 [Full text]
Hensley LE, Fritz E, Jahrling PB, et al. Interferon-beta 1a and SARS coronavirus replication. Emerg Infect Dis 2004 Feb;10(2):317-9 [Full text]
Heymann DL, Rodier G. Global surveillance, national surveillance, and SARS. (Commentary) Emerg Infect Dis 2004 Feb;10(2):173-5 [Full text]
Ho AS, Sung JJY, Chan-Yeung M. An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong. Ann Intern Med 2003 Oct 7;139(7):564-7 [Abstract]
Ho KY, Singh K, Habib A, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 2004 Feb 15;189(4):642-7 [Abstract]
Ho MS, Chen WJ, Chen HY, et al. Neutralizing antibody response and SARS severity. Emerg Infect Dis 2005 Nov;11(11):1730-7 [Full text]
Ho W. Guideline on management of severe acute respiratory syndrome (SARS). (Commentary) Lancet 2003 Apr 19;361(9366):1313-5 [Abstract]
Holms KV. SARS-associated coronavirus. (Perspective) N Engl J Med 2003 May 15;348(20):1948-51 [Full text]
Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. (Research Letter) Lancet 2003 May 17;361(9370):1701-2 [Abstract]
Hopkins RS, Misegades L, Ransom J, et al. SARS preparedness checklist for state and local health officials. Emerg Infect Dis 2004 Feb;10(2):369-72 [Full text]
Hourfar MK, Roth WK, Seifried E, et al. Comparison of two real-time quantitative assays for detection of SARS coronavirus. J Clin Microbiol 2004 May;42(5):2094-100 [Abstract]
Hsieh Y-H, Chen CWS, Jsu S-B. SARS outbreak, Taiwan, 2003. Emerg Infect Dis 2004 Feb;10(2):201-6 [Full text]
Hsieh YH, King CC, Chen CWS, et al. Quarantine for SARS, Taiwan. Emerg Infect Dis 2005 Feb;11(2):278-82 [Full text]
Hsieh YH, Lee JY, Chang HL. SARS epidemiology modeling. (Letter) Emerg Infect Dis 2004 Jun;10(6):1165-8 [Full text]
Hsu L-Y, Lee C-C, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003 Jun;9(6):713-7 [Full text]
Hsueh P-R, Chen P-J, Hsiao C-H, et al. Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis 2004 Mar;10(3):489-93 [Full text]
Hsueh P-R, Hsiao C-H, Yeh S-H, et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003 Sep;9(9):1063-7 [Full text]
Hsueh PR, Kao CL, Lee CN, et al. SARS antibody test for serosurveillance. Emerg Infect Dis 2004 Sep;10(9):1558-62 [Full text]
Huang Y, Yang Z-Y, Kong W-P, et al. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J Virol 2004 Nov;78(22):12557-65 [Abstract]
Hughes JM. The impressive and rapidly expanding knowledge base on SARS. (Commentary) Emerg Infect Dis 2004 Feb;10(2):171-2 [Full text]
Hui PSC, Chan PKS. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010 Sep;24(3):619-38 [Abstract]
Hui RKH, Zeng F, Chan CMN, et al. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol 2004 May;42(5):1994-9 [Abstract]
Hung IFN, Cheng VCC, Wu AKL, et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004 Sep;10(9):1550-7 [Full text]
Imai T, Takahashi K, Hoshuyama T, et al. SARS risk perceptions in healthcare workers, Japan. Emerg Infect Dis 2005 Mar;11(3):404-10 [Full text]
Institute for Bioethics, Health Policy and Law, University of Louisville School of Medicine. Quarantine and isolation: lessons learned from SARS. Nov 2003 [Full text]
IOM (Institute of Medicine). Learning from SARS: preparing for the next disease outbreak. Summary of Sep 30-Oct 1, 2003, Forum on Microbial Threats workshop. Prepublication version. Washington, DC: National Academies Press, 2004 [Full text]
IOM (Institute of Medicine). Microbial threats to health: emergence, detection, and response. Mar 18, 2003 [Full text]
Ip M, Chan PKS, Lee N, et al. Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clin Infect Dis 2004 Jun 15;38(12):e116-8 [Abstract]
Ip WK, Chan KH, Law HK, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005 May 15;191(10):1697-704 [Abstract]
Isakbaeva ET, Khetsuriani N, Beard RS, et al SARS-associated coronavirus transmission, United States. Emerg Infect Dis 2004 Feb;10(2):225-31 [Full text]
Jefferson T, Foxlee R, Del Mar C, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207 [Abstract]
Jernigan JA, Low DE, Helfand RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004 Feb;10(2):327-33 [Full text]
Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis 2005 Jul;11(7):1016-20 [Full text]
Jiang SS, Chen TC, Yang JY, et al. Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin Infect Dis 2004 Jan 15;38(2):293-6 [Abstract]
Johnston RE. A candidate vaccine for severe acute respiratory syndrome. N Engl J Med 2004 Aug 19;351(8):827-8 [Extract]
Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature 2008 Feb 21;451(7181):990-3 [Abstract]
Joyntand GM, Yap HY. SARS in the intensive care unit. Curr Infect Dis Rep 2004 Jun;6(3):228-33 [Abstract]
Karesh WB, Cook RA, Gilbert M, et al. Implications of wildlife trade on the movement of avian influenza and other infectious diseases. J Wildl Dis 2007 Jul;43(3 suppl):S55-9 [Abstract]
Kaydos-Daniels SC, Olowokure B, Chang H-J, et al. Body temperature monitoring and SARS fever hotline, Taiwan. Emerg Infect Dis 2004 Feb;10(2):373-6 [Full text]
Kaye M, Druce J, Tran T, et al. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis 2005 Jan;12(1):128-33 [Full text]
Kim TW, Lee JH, Hung C-F, et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2004 May;78(9):4638-45 [Abstract]
Knowles SR, Phillips EJ, Dresser L, et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. 2003 Oct 15;37(8):1139-42 [Abstract]
Koh D, Takahashi K, Lim MK, et al. SARS risk perception and preventive measures, Singapore and Japan. (Letter) Emerg Infect Dis 2005 Apr;11(4):641-2 [Full text]
Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003 May 15;348:1953-66 [Full text]
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005 Aug;11(8):875-9 [Abstract]
La Montagne JR, Simonsen L, Taylor RJ, et al. Severe acute respiratory syndrome: developing a research response. J Infect Dis 2004 Feb 15;189(4):634-41 [Abstract]
Lai KN, Tsang KW, Seto WH, et al. Clinical, laboratory, and radiological manifestation of SARS. Curr Infect Dis Rep 2004 Jun;6(3):213-9 [Abstract]
Lai MYY, Cheng PKC, Lim WWL. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 2005 Oct 1;41(7):e67-71 [Abstract]
Lan YC, Liu TT, Yang JY, et al. Molecular epidemiology of severe acute respiratory syndrome-associated coronavirus infections in Taiwan. J Infect Dis 2005 May 1;191(9):1478-89 [Abstract]
Lancet Editors. Will SARS hurt the world's poor? (Editorial) Lancet 2003 May 3;361(9368):1485 [Abstract]
Lau EHY, Hsiung AC, Cowling BJ, et al. A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMJ Infect Dis 2010 Mar 6;10:50 [Abstract]
Lau JT, Tsui J, Lau M, et al. SARS transmission, risk factors, and prevention, Hong Kong. Emerg Infect Dis 2004 Apr;10(4):587-92 [Full text]
Lau JTF, Fung KS, Wong TW, et al. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004 Feb;10(2):280-5 [Full text]
Lau JTF, Lau M, Kim JH, et al. Probable secondary infections in households of SARS patients in Hong Kong. Emerg Infect Dis 2004 Feb;10(2):235-4 [Full text]
Lau JTF, Yang X, Leung PC, et al. SARS in three categories of hospital workers, Hong Kong. Emerg Infect Dis 2004 Aug;10(8):1399-404 [Full text]
Lau JTF, Yang X, Pang E, et al. SARS-related perceptions in Hong Kong. Emerg Infect Dis 2005 Mar;11(3):417-24 [Full text]
Lau K-K, Yu W-C, Chu D-M, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004 Feb;10(2):342-4 [Full text]
Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci 2005 Sep 27;102(39):14040-5 [Abstract]
Lau SK, Woo PC, Wong BH, et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. J Clin Microbiol 2004 Jul;42(7):2884-9 [Abstract]
Lawler JV, Endy TP, Hensley LE, et al. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med 2006 May;3(5):e149 [Full text]
Lee DT, Wing YK, Leung HC, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis 2004 Oct 15;39(8):1247-9 [Abstract]
Lee HKK. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. (Letter) Emerg Infect Dis 2003 Nov;9(11):1491-2 [Full text]
Lee N, Hui D, Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 May 15;348(20):1986-94 [Full text]
Lee N, Sung JJ. Nosocomial transmission of SARS. Curr Infect Dis Rep 2003 Dec;5(6):473-6 [Abstract]
Leong HN, Chan KP, Khan AS, et al. Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital. Emerg Infect Dis 2004 Oct;10(10):1745-50 [Full text]
Lessler J, Reich NG, Brookmeyer R, et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009 May;9(5):291-300 [Abstract]
Leung GM, Chung PH, Tsang T, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis 2004 Sep;10(9):1653-6 [Full text]
Leung GM, Ho LM, Chan SKK, et al. Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. Clin Infect Dis 2005 Jun 15;40(12):1713-20 [Abstract]
Leung GM, Quah S, Ho LM, et al. A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic. Infect Control Hosp Epidemiol 2004 Dec;25(12):1033-41 [Abstract]
Leung GM, Rainer TH, Lau FL, et al. A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med 2004 Sep 7;141(5):333-42 [Abstract]
Li B-j, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature 2005 Sep;11:907-1011 [Abstract]
Li L, Gu J, Shi X, et al. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects. Clin Infect Dis 2005 Sep 15;41(6):815-21 [Full text]
Li T, Qiu Z, Zhang L, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 2004 Feb 15;189(4):648-51 [Abstract]
Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronavirus. Science 2005 Oct 28;310(5748):676 [Abstract]
Liang G, Chen Q, Xu J, et al. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis 2004 Oct;10(10):1774-81 [Full text]
Liang W, Zhu Z, Guo J, et al. Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis 2004 Jan;10(1):25-31 [Full text]
Lim PL, Kurup A, Gopalakrishna G, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004 Apr 22;350(17):1740-5 [Abstract]
Lin ECL, Peng YC, Tsai JCH. Lessons learned from the anti-SARS quarantine experience in a hospital-based fever screening station in Taiwan. Am J Infect Control 2010 May;38(4):302-7 [Abstract]
Lingappa JR, McDonald LC, Simone P, et al. Wresting SARS from uncertainty. (Commentary) Emerg Infect Dis 2004 Feb;10(2):167-70 [Full text]
Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003 Jun 20;300(5627):1966-70 [Abstract]
Liu W, Fontanet A, Zhang PH. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis 2006 Mar 15;193(6):792-5 [Abstract]
Liu W, Tang F, Fontanet A, et al. Long-term SARS coronavirus excretion from patient cohort, China. Emerg Infect Dis 2004 Oct;10(10):1841-3 [Full text]
Liu W, Tang F, Fontanet A, et al. Molecular epidemiology of SARS-associated coronavirus, Beijing. Emerg Infect Dis 2005 Sep;11(9):1420-4 [Full text]
Lo JYC, Tsang THF, Leung YH, et al. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis 2005 Nov;11(11):1738-41 [Full text]
Loeb M, McGeerA, Henry B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004 Feb;10(2):251-5 [Full text]
Loeb MB. Severe acute respiratory syndrome: preparedness, management, and impact. (Editorial) Infect Control Hosp Epidemiol 2004 Dec;25(12):1017-9 [Abstract]
Loon S-C, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004 Jul;88:861-3 [Abstract]
Louis JK, Hacker JK, Mark J, et al. SARS and common viral infections. Emerg Infect Dis 2004 Jun;10(6):1143-6 [Full text]
Loutfy MR, Wallington T, Rutledge T, et al. Hospital preparedness and SARS. (Perspective) Emerg Infect Dis 2004 May;10(5):771-6 [Full text]
Low DE, McGeer A. SARS: one year later. (Perspective) N Engl J Med 2003 Dec 18;349(25):2381-2 [Extract]
Low JGH, Lee CC, Leo YS, et al. Severe acute respiratory syndrome and pulmonary tuberculosis. Clin Infect Dis 2004 Jun 15;38(12):e123-5 [Abstract]
Lu L, Manopo I, Leung BP, et al. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004 Apr;42(4):1570-6 [Abstract]
Mahony JB, Petrich A, Louie L, et al. Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of SARS coronavirus. J Clin Microbiol 2004 Apr;42(4):1471-6 [Abstract]
Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003 May 30;300(5624):1399-404 [Abstract]
Martin JE, Louder MK, Holman LA, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a phase I clinical trial. Vaccine 2008 Nov 25;26(50):6338-43 [Abstract]
Martina BE, Haagmans BL, Kuiken T, et al. Virology: SARS virus infection of cats and ferrets. Nature 2003 Oct 30;425:915 [Abstract]
Matsuyama S, Ujike M, Morikawa S, et al. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci 2005 Aug 30;102(35):12543-7 [Abstract]
Maunder RG, Lancee WJ, Balderson KE, et al. Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerg Infect Dis 2006 Dec;12(12):1924-32 [Full text]
Mazzulli T, Farcas GA, Poutanen SM, et al. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004 Jan 10(1):20-4 [Full text]
McDonald LC, Simor AE, Su I-J, et al. SARS in healthcare facilities, Toronto and Taiwan. (Perspective) Emerg Infect Dis 2004 May;10(5):777-81 [Full text]
McGeer A. Let him who desires peace prepare for war: United States hospitals and severe acute respiratory syndrome preparedness. (Commentary) Clin Infect Dis 2004 Jul 15;39(2):275-7 [Full text]
Meltzer MI. Multiple contact dates and SARS incubation periods. Emerg Infect Dis 2004 Feb;10(2):207-9 [Full text]
Misrahi JJ, Foster JA, Shaw FE, et al. HHS/CDC legal response to SARS outbreak. Emerg Infect Dis 2004 Feb;10(2):353-5 [Full text]
Miyoshi-Akiyama T, Ishida I, Fukushi M, et al. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a Rhesus macaque SARS model. J Infect Dis 2011 Jun 1;203(11):1574-81 [Abstract]
Moore D, Gamage B, Bryce E, et al. Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines. Am J Infect Control 2005 Mar;33(2):88-96 [Abstract]
Muller MP, McGeer A, Straus SE, et al. Clinical trials and novel pathogens: lessons from SARS. Emerg Infect Dis 2004 Mar;10(3):389-94 [Full text]
Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005 Apr 15;40(8):1079-86 [Abstract]
Mullin S. New York City's communication trials by fire, from West Nile to SARS. Biosecurity Bioterrorism 2003 Jul 5;1(4):267-72 [Abstract]
Nandi A, Tracy M, Aiello A, et al. Social support and response to AIDS and severe acute respiratory syndrome. Emerg Infect Dis 2008 May;14(5):825-7 [Full text]
National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004 Jul 22;351(4):327-36 [Abstract]
Ng MHL, Lau KM, Li L, et al. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 2004 Aug 1;190(3):515-8 [Abstract]
Ng ML, Lee JW, Leong ML, et al. Topographic changes in SARS coronavirus-infected cells at late stages of infection. Emerg Infect Dis 2004 Nov;10(11):1907-14 [Full text]
Ng SK. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet 2003 Aug 16; 362(9383):570-2 [Abstract]
Nicholls JM, Butany J, Poon LL, et al. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 2006 Feb;3(2):e27 [Webpage]
Nicholls JM, Poon LM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003 May 24;361(9371):1773-8 [Abstract]
Nie Y, Wang G, Shi X, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004 Sep 15;190(6):1119-26 [Abstract]
Nitsche A, Schweiger B, Ellerbrok H, et al. SARS coronavirus detection. Emerg Infect Dis 2004 Jul;10(7):1300-3 [Full text]
Olsen SJ, Chang H-L, Cheung TY-Y, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 2003 Dec 18;349(25):2416-22 [Abstract]
Parashar UD, Anderson LJ. SARS preparedness and response planning. (Conference summary) Emerg Infect Dis 2004 Feb;10(2):384-5 [Full text]
Park BJ, Peck AJ, Kuehnert MJ, et al. Lack of SARS transmission among healthcare workers, United States. Emerg Infect Dis 2004 Feb;10(2):244-8 [Full text]
Peck AJ, Newbern EC, Feikin DR, et al. Lack of SARS transmission and U.S. SARS case-patient. Emerg Infect Dis 2004 Feb;10(2):217-24 [Full text]
Peiris JS, Yuen KY, Osterhaus AD, et al. The severe acute respiratory syndrome. N Engl J Med 2003 Dec 18;349(25):2431-41 [Extract]
Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003 May 24;361(9371):1767-72 [Abstract]
Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003 Apr 19;361(9366):1319-25 [Abstract]
Person B, Sy F, Holton K, et al. Fear and stigma: the epidemic within the SARS outbreak. Emerg Infect Dis 2004 Feb;10(2):358-63 [Full text]
PHAC (Public Health Agency of Canada). Learning from SARS. Report of the National Advisory Committee on SARS and Public Health. Oct 2003 [Full text]
Pitzer VE, Leung GM, Lipsitch M. Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China. Am J Epidemiol 2007 Aug 1;166(3):355-63 [Abstract]
Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 May 15;348(20):1995-2005 [Full text]
Poutanen SM, McGeer AJ. Transmission and control of SARS. Curr Infect Dis Rep 2004 Jun;6(3):200-7 [Abstract]
Qu D, Zheng B, Yao X, et al. Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine 2005 Jan 4;23(7):924-31 [Abstract]
Quah SR, Hin-Peng L, et al. Crisis prevention and management during SARS outbreak. Singapore. Emerg Infect Dis 2004 Feb;10(2):364-8 [Full text]
Raboud J, Shigayeva A, McGeer A, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS ONE 2010 May 19;5(5):e10717 [Full text]
Razum O, Becher H, Kapaun A, et al. SARS, lay epidemiology, and fear. (Correspondence) Lancet 2003 May 17;361(9370):1739-50 [Abstract]
Reilley B, Van Herp M, Sermand D, et al. SARS and Carlo Urbani. (Perspective) N Engl J Med 2003 May 15;348(20):1951-2 [Full text]
Rest JS, Mindell DP. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. Infect Genet Evol 2003 Sep;3(3):219-25 [Abstract]
Richards EP, Rathbun KC. Making state public health laws work for SARS outbreaks. Emerg Infect Dis 2004 Feb;10(2):356-7 [Full text]
Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiologic agent of SARS in Hong Kong: impact of public health interventions. Science 2003 Jun 20;300(5627):1961-6 [Abstract]
Roberts A, Thomas WD, Guarner J, et al. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity amd viral burden in golden Syrian hamsters. J Infect Dis 2006 Mar 1;193(5):685-92 [Abstract]
Robertson CA, Lowther SA, Birch T, et al. SARS and pregnancy: a case report. Emerg Infect Dis 2004 Feb;10(2):345-8 [Full text]
Rockx B, Corti D, Donaldson E, et al. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. J Virol 2008 Apr;82(7):3220-35 [Abstract]
Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003 May 30;300(5624):1394-9 [Abstract]
Ruan Y, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003 May 24;361(9371):1779-85 [Abstract]
Sampath R, Hofstadler SA, Blyn LB, et al. Rapid identification of emerging pathogens: coronavirus. Emerg Infect Dis 2005 Mar;11(3):373-9 [Full text]
Scales DC, Green K, Chan AD, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003 Oct;9(10):1205-10 [Full text]
Schaecher SR, Stabenow J, Oberle C,et al. An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology 2008 Oct 25;380(2):312-21 [Abstract]
Schrag SJ, Brooks JT, Van Beneden C, et al. SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis 2004 Feb;10(2):185-94 [Full text]
Scott RD II, Gregg E, Meltzer MI. Collecting data to assess SARS Interventions. Emerg Infect Dis 2004 Jul;10(7):1290-2 [Full text]
See RH, Petric M, Lawrence DJ, et al. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. J Gen Virol 2008 Sep;89(9):2136-46 [Abstract]
Seto WH, Tsang D, Yung RWH, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). (Research Letter) Lancet 2003 May 3;361(9368):1519-20 [Abstract]
Sheahan T, Whitmore A, Long K, et al. Successful vaccination strategies that protect aged mice from lethal influenza and lethal heterologous SARS-CoV challenge. J Virol 2011 Jan;85(1):217-30 [Abstract]
Shek CC, Ng PC, Fung GPG, et al. Infants born to mothers with severe acute respiratory syndrome. Pediatrics 2003 Oct;112:e254 [Abstract]
Shen Z, Ning F, Zhou W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004 Feb;10(2):256-60 [Full text]
Shi Y, Yi Y, Kuang T, et al. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol 2003 Dec;41(12):5781-2 [Abstract]
Shigayeva A, Green K, Raboud JM, et al. Factors associated with critical-care healthcare workers' adherence to recommended barrier precautions during the Toronto severe acute respiratory syndrome outbreak. Infect Control Hosp Epidemiol 2007 Nov;28(11):1275-83 [Abstract]
Shih FY, Yen MY, Wu JS, et al. Challenges faced by hospital healthcare workers in using a syndrome-based surveillance system during the 2003 outbreak of severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 2007 Mar;28(3):354-7 [Abstract]
Silverman A, Simor A, Loutfy MR. Toronto emergency medical services and SARS. (Letter) Emerg Infect Dis 2004 Sep;10(9):1688-9 [Full text]
Sims AC, Baric RS, Yount B, et al. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 2005 Dec;79(24):15511-24 [Abstract]
Singh K, Eong OE, Kumarsil B, et al. Severe acute respiratory syndrome without respiratory symptoms or abnormal chest radiograph findings. Clin Infect Dis 2004 Feb 15;38(4):585-6 [Abstract]
Singh K. Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis 2003 Oct;9(10):1284-96 [Full text]
Sit SC, Yau EKC, Lam YY, et al. A young infant with severe acute respiratory syndrome. Pediatrics 2003 Oct;112:e257 [Abstract]
Skowronski DM, Petric M, Daly P, et al. Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis 2005 Jan;12(1):155-8 [Full text]
Smits SL, van den Brand JMA, de Lang A, et al. Distinct SARS-coronavirus induced acute lung injury pathways in two different non-human primate species. J Virol 2011 May;85(9):4234-45 [Abstract]
Song HD, Tu CC, Zhang GW, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci 2005 Feb 15;102(7):2430-5 [Full text]
Srikantiah P, Charles MD, Reagan S, et al. SARS clinical features, United States, 2003. Emerg Infect Dis 2005 Jan;11(1):135-8 [Full text]
Srinivasan A, Jernign DB, Liedtke L, et al. Hospital preparedness for severe acute respiratory syndrome in the United States: views from a national survey of infectious diseases consultants. Clin Infect Dis 2004 Jul 15;39(2):272-4 [Abstract]
Srinivasan A, McDonald L, Jernigan D, et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol 2004 Dec;25(12):1020-5 [Abstract]
St John RK, King A, de Jong D, et al. Border screening for SARS. Emerg Infect Dis 2005 Jan 11(1):6-10 [Full text]
Stadler K, Roberts A, Becker S, et al. SARS vaccine protective in mice. (Letter) Emerg Infect Dis 2005 Aug;11(8):1312-4 [Full text]
Stavrinides J, Guttman DS. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol 2004 Jan;78(1):76-82 [Abstract]
Stein RA. Super-spreaders in infectious diseases. Int J Infect Dis 2011 Aug;15(8):e510-3 [Abstract]
Stockman LA, Lowther SA, Coy K, et al. SARS during pregnancy, United States. (Letter) Emerg Infect Dis 2004 Sep;10(9):1689-90 [Full text]
Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006 Sep;3(9):e343 [Full text]
Stockman LJ, Massoudi MS, Helfand R, et al. Severe acute respiratory syndrome in children. Ped Infect Dis J 2007 Jan;26(1):68-74 [Abstract]
Stroher U, DiCaro A, Li Y, et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha. J Infect Dis 2004 Apr 1;189(7):1164-7 [Abstract]
Stukel TA, Schull MJ, Guttmann A, et al. Health impact of hospital restrictions on seriously ill hospitalized patients: lessons from the Toronto SARS outbreak. Med Care 2008 Sep;46(9):991-7 [Abstract]
Subbarao K, McAuliffe J, Vogel L, et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004 Apr;78(7):3572-7 [Abstract]
Sui J, Aird DR, Tamin A, et al. Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog 2008 Nov 7;4(11):e1000197 [Full text]
Sui J, Li W, Murakami A, et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci 2004 Feb 24;101(8):2536-41 [Abstract]
Svoboda T, Henry B, Shulman L, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med 2004 Jun 3;350(23):2352-61 [Abstract]
Swayne DE, Suarez DL, Spackman E, et al. Domestic poultry and SARS coronavirus, southern China. Emerg Infect Dis 2004 May;10(5):914-6 [Full text]
Tai HTC, Le MQ, Vuong CD, et al Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004 May;42(5):1956-61 [Abstract]
Tam DKP, Lee S, Lee SS. Impact of SARS on avian influenza preparedness in healthcare workers. Infection 2007 Oct;35(5):320-5 [Abstract]
Tam DKP, Lee SS, Lee S. Impact of severe acute respiratory syndrome and the perceived avian influenza epidemic on the increased rate of influenza vaccination among nurses in Hong Kong. Infect Control Hosp Epidemiol 2008 Mar;39(3):256-61 [Abstract]
Tan EL, Ooi EE, Lin C-Y, et al. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 2004 Apr;10(4):581-6 [Full text]
Tan TT, Tan BH, Kurup A, et al. Aypical SARS and Escherichia coli bacteremia. Emerg Infect Dis 2004 Feb;10(2):349-52 [Full text]
Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med 2007 Jun 25;167(12):1312-20 [Abstract]
Taylor J, Wentworth DE, Bernard KA, et al. SARS coronaviruses and highly pathogenic influenza viruses: safety and occupational health for laboratory workers. (Conference Summary) Emerg Infect Dis 2005 Apr;11(4) [Full text]
Tee AKH, Oh HML, Hui KP, et al. Atypical SARS in geriatric patient. Emerg Infect Dis 2004 Feb;10(2):261-4 [Full text]
Temperton NJ, Chan PK, Simmons G, et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 2005 Mar;11(3):411-6 [Full text]
The PloS Medicine Editors. Journals, academics and pandemics. (Editorial) PloS Med 2010 May 25;7(5):e1000282 [Full text]
Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. (Commentary) Lancet 2003 May 3;361(9368):1486-7 [Abstract]
Tong TR. Airborne severe acute respiratory syndrome coronavirus and its implications. (Editorial Commentary) J Infect Dis 2005 May 1;191(9):1401-2 [Abstract - See also Booth above]
Tong TR. SARS-CoV sampling from 3 portals. (Letter) Emerg Infect Dis 2005 Jan;11(1):167 [Full text]
Traggiai E, Becker S, Subbarao K, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nature Med 2004 Aug;19(8):871-5 [Abstract]
Trust for America's Health. SARS and its implications for US public health policy: "We've been lucky." May 2003 [Full text]
Tsai S-H, Tsang C-M, Wu H-R, et al. Transporting patient with suspected SARS. (Letter) Emerg Infect Dis 2004 Jul;10(7):1325-6 [Full text]
Tsang HWH, Scudds RJ, Chan EYL. Psychosocial impact of SARS. (Letter) Emerg Infect Dis 2004 Jul;10(7):1326-7 [Full text]
Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 May 15;348(20):1977-85 [Full text]
Tsang OT-Y, Chau T-N, Choi K-W, et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 2003 Nov;9(11):1381-7 [Full text]
Tsui PT, Kwok ML, Yuen H, et al. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003 Sep;9(9):1064-9 [Full text]
Twu S-J, Chen T-J, Chen C-J, et al. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003 Jun;9(6):718-20 [Full text]
Van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nature Med 2004 Apr;10(4):368-73 [Abstract]
Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Can Med Assoc J 2003 Aug 19;169(4):285-92 [Abstract]
Vicenzi E, Canducci F, Pinna D, et al. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis 2004 Mar;10(3):413-8 [Full text]
Vinayagamoorthy T, Mulatz K, Hodkinson R. Identification of the severe acute respiratory syndrome coronavirus by simultaneous multigene DNA sequencing. J Clin Microbiol 2004 Jul;42(&):3291-4 [Abstract]
Vu HT, Leitmeyer KC, Le DH, et al. Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerg Infect Dis 2004 Feb;10(2):334-8 [Full text]
Vu SL, Yazdanpanah Y, Bitar D, et al. Absence of infection in asymptomatic contacts of index SARS case in France. Eurosurveillance Monthly 2006 Jan;11(1):pii=593 [Full text]
Wang B, Potter SJ, Lin Y, et al. Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. J Clin Microbiol 2005 May;43(5):2339-44 [Abstract]
Wang J-T, Sheng W-H, Fang C-T, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis 2004 May;10(5):818-24 [Full text]
Wang L-F, Shi Z, Zhang S, et al. Review of bats and SARS. Emerg Infect Dis 2006 Dec;12(12):1834-40 [Full text]
Wang M, Yan M, Xu H, et al. SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis 2005 Dec;11(12):1860-5 [Full text]
Wang TH, Wei KC, Hsiung CA, et al. Optimizing severe acute respiratory syndrome response strategies: lessons learned from quarantine. Am J Public Health 2007 Apr;97(Suppl 1):S98-100 [Abstract]
Wang WK, Chen SY, Liu IJ, et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004 Jul;10(7):1213-9 [Full text]
Watts DM, Peters CJ, Newman P, et al. Evaluation of cotton rats as a model for severe acute respiratory syndrome. Vector-Borne Zoonotic Dis 2008 Jun 1;8(3):339-44 [Abstract]
Watts J. China takes drastic action over SARS threat. Lancet 2003 May 17;361(9370):1708-9 [Abstract]
Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 2004 Nov;78(22):12672-6 [Abstract]
Weingartl HM, Copps J, Drebot MA, et al. Suseptibility of pigs and chickens to SARS coronavirus. Emerg Infect Dis 2004 Feb;10(2):179-4 [Full text]
Weinstein RA. Planning for epidemics: the lessons of SARS. N Engl J Med 2004 Jun 3;350(23):2332-4 [Extract]
Wentworth DE, Gillim-Ross L, Espina N, et al. Mice susceptible to SARS coronavirus. Emerg Infect Dis 2004 Jul;10(7):1293-6 [Full text]
Wenzel RP, Edmond MB. Listening to SARS: lessons for infection control. (Editorial) Ann Intern Med 2003 Oct 7;139(7):592-3 [Full text]
Wenzel RP, Edmond MB. Managing SARS amidst uncertainty. (Perspective) N Engl J Med 2003 May 15;348(20):1947-8 [Full text]
WHO. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003 May 17;361(9370):1730-3 [Abstract]
WHO. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Oct 17, 2003 [Full text]
WHO. SARS: breaking the chains of transmission. Jul 5, 2003 [Full text]
WHO. SARS: lessons from a new disease. In: The World Health Report 2003: shaping the future. Chap 5 [Full text]
WHO. WHO SARS International Reference and Verification Laboratory Network: SARS policy and procedures in the inter-epidemic period. Jan 23, 2004 [Full text]
Wilder-Smith A, Earnest A, Paton NI. Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from Dengue fever. Clin Infect Dis 2004 Dec 15;39(12):1818-23 [Abstract]
Wilder-Smith A, Teleman MD, Heng BH, et al. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis 2005 July;11(7):1142-5 [Full text]
Wong RSM, Hui DS. Index patient and SARS outbreak in Hong Kong. Emerg Infect Dis 2004 Feb;10(2):339-41 [Full text]
Wong T, Wallington T, McDonald C, et al. Late recognition of SARS in nosocomial outbreak, Toronto. Emerg Infect Dis 2005 Feb;11(2):322-5 [Full text]
Wong T-W, Lee C-K, Tam W, et al. Cluster of SARS among medical students exposed to single patients, Hong Kong. Emerg Infect Dis 2004 Feb;10(2):269-76 [Full text]
Wong TK, Chung JW, Li Y, et al. Effective personal protective clothing for health care workers attending patients with severe acute respiratory syndrome. Am J Infect Control 2004 Apr;32(2):90-6 [Abstract]
Woo PC, Lau SK, Tsoi H-w, et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004 Mar 13;363(9412):841-5 [Abstract]
Woo PC, Lau SK, Wong BH, et al. Differential sensitivities of SARS coronavirus spike polypeptide ELISA and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2005 Jul;43(7):3054-8 [Abstract]
Woo PCY, Lau SKP, Wong BHL, et al. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2004 May;42(5):2306-9 [Abstract]
Wu EB, Sung JJY. Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS. (Research Letter) Lancet 2003 May 3;361(9368):1520-1 [Abstract]
Wu H-S, Chiu S-C, Tseng R-C, et al. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg Infect Dis 2004 Feb;10(2):304-10 [Full text]
Wu J, Xu J, Zhou W, et al Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis 2004 Feb;10(2):210-6 [Full text]
Wu KK, Chan SK, Ma TM. Posttraumatic stress after SARS. Emerg Infect Dis 2005 Aug;11(8):1297-300 [Full text]
Wu LP, Wang NC, Chang YH, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis 2007 Oct;13(10):1562-4 [Full text]
Xing W, Hejblum G, Leung GM, et al. Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review. PLoS Med 2010 May 4;7(5):e1000272 [Full text]
Xu D, Zhang Z, Chu F, et al. Genetic variation of SARS coronavirus in Beijing hospital. Emerg Infect Dis 2004 May;10(5):789-94 [Full text]
Xu J, Zhong S, Liu J, et al. Detections of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine Mig in pathogenesis. Clin Infect Dis 2005 Oct 15;41(8):1089-96 [Abstract]
Xu RH, He JF, Evans MR, et al. Epidemiologic clues to SARS origin in China. Emerg Infect Dis 2004 Jun;10(6):1030-7 [Full text]
Yam WC, Chan KH, Poon LLM, et al. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 2003 Oct 1;41(10):4521-4 [Abstract]
Yang Z-Y, Kong W-P, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004 Apr 1;428(6982):561-4 [Full text]
Yang ZY, Werner HC, Kong WP, et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci 2005 Jan 18;102(3):797-801 [Abstract]
Yeh S-H, Wang H-Y, Tsai C-Y, et al. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci 2004 Feb 24;101(8):2542-7 [Abstract]
Yip PSF, Hsieh YH, Xu Y, et al. Assessment of intervention measures for the 2003 SARS epidemic in Taiwan by use of a back-projection method. Infect Control Hosp Epidemiol 2007 May;28(5):525-30 [Abstract]
Yu IT, Xie ZH, Tsoi KK, et al. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis 2007 Apr 15;44(8):1017-25 [Abstract]
Yu ITS, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004 Apr 22;350(17):1731-9 [Abstract]
Yu ITS, Wong TW, Chiu YL, et al. Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis 2005 May 1;40(9):1237-43 [Abstract]
Yuan FF, Boehm I, Chan PKS, et al. CD14-159CC, another risk genotype for severe SARS-CoV infection. Clin Vaccine Immunol 2007 Dec;14(12):1644-5 [Abstract]
Zhai J, Briese T, Dai E, et al. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004 Feb;10(2):300-3 [Full text]
Zhang X, Alekseev K, Jung K, et al. Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome. J Virol 2008 May 1;82(9):4420-8 [Abstract]
Zhao J, Zhao J, Perlman S. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol 2010 Sep;84(18):9318-25 [Abstract]
Zheng BJ, Guan Y, Wong KH, et al. SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis 2004 Feb;10(2):176-8 [Full text]
Zhou G, Yan G. Severe acute respiratory syndrome epidemic in Asia. Emerg Infect Dis 2003 Dec;9(12):1608-10 [Full text]
Zhu H, Hu S, Jona G, et al. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc Natl Acad Sci 2006 Mar 14;103(11):4011-6 [Abstract]
Zou Z, Yang Y, Chen J, et al. Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin Infect Dis 2004 Feb 15;38(4):483-9 [Abstract]
|
